Neslihan Büküm
- Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
2018/08/03 by Eva Novotná, Neslihan Büküm, Jakub Hofman +5 · 11 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Alcohol Consumption and Health Effects #Aldo-keto reductase #Aldose Reductase and Taurine #Anthracycline #Biochemistry #Biology #Cancer #Cancer cell #Cancer research #Chemotherapy #Cofactor #Daunorubicin #Enzyme #Genetics #Heme Oxygenase-1 and Carbon Monoxide #NAD+ kinase #Pharmacology #Reductase